Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 5 47-5, 2003, Pages

  Henriksen, Erik J ^a   Kinnick, Tyson R ^a   Teachey, Mary K ^a   O'Keefe, Matthew P ^a   Ring, David ^b   Johnson, Kirk W ^b   Harrison, Stephen D ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Cell surface glucose transporter 4; Epitrochlearis; Glucose transport; Glycogen synthase kinase 3; Lithium; Soleus; Type 2 diabetes

Indexed keywords

CT 98014; CT 98023; ENZYME INHIBITOR; GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; INSULIN; LITHIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG TISSUE LEVEL; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE TRANSPORT; INSULIN RESISTANCE; INSULIN RESPONSE; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT; RAT STRAIN; SKELETAL MUSCLE; SOLEUS MUSCLE;

EID: 0037405647     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00346.2002     Document Type: Article

References (37)

1. Ariano MA, Armstrong RB, and Edgerton VR. Hindlimb muscle fiber populations of five animals. J Histochem Cytochem 21: 51-55, 1973.
2. Brozinick JT, Misener EA, Ni B, Ryder JW, and Dohm GL. Impaired insulin signaling through GSK3 in insulin resistant skeletal muscle (Abstract). Diabetes 49, Suppl 1: A326, 2000.
3. Choi WS and Sung CK. Effects of lithium and insulin on glycogen synthesis in L6 myocytes: additive effects on inactivation of glycogen synthase kinase-3. Biochim Biophys Acta 1475: 225-230, 2000.
4. Cline GW, Johnson K, Regittnig W, Perret P, Tozzo E, Xiao L, Damico C, and Shulman GI. Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes 51: 2903-2910, 2002.
5. Coghlan MP, Culbert AA, Cross DAE, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GL, Carter PS, Cox LR, Mills D, Brown MJ, Haigh D, Ward RW, Smith DG, Murray KJ, Reith AD, and Holder JC. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol 24: 1-11, 2000.
6. Cortez MY, Torgan CE, Brozinick JT, and Ivy JL. Insulin resistance of obese Zucker rats exercise trained at two different intensities. Am J Physiol Endocrinol Metab 261: E613-E619, 1991.
7. Cross DA, Alessi DR, Cohen P, Andjelkovich M, and Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789, 1995.
8. Davies SP, Reddy H, Caviano M, and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105, 2000.
9. DeFronzo RA and Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194, 1991.
10. Eldar-Finkelman H and Krebs EG. Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc Natl Acad Sci USA 94: 960-9664, 1997.
11. Eldar-Finkelman H, Schreyer SA, Shinohara MM, Le-Boeuf RC, and Krebs EG. Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. Diabetes 48: 1662-1666, 1999.
12. Hansen PA, Gulve EA, and Holloszy JO. Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle. J Appl Physiol 76: 979-985, 1994.
13. Henriksen EJ, Bourey RE, Rodnick KJ, Koranyi L, Permutt MA, and Holloszy JO. Glucose transporter protein content and glucose transport capacity in rat skeletal muscles. Am J Physiol Endocrinol Metab 259: E593-E598, 1990.
14. Henriksen EJ and Halseth AE. Early alterations in soleus GLUT-4, glucose transport, and glycogen in voluntary running rats. JAppl Physiol 76: 1862-1867, 1994.
15. Henriksen EJ, Tischler ME, and Johnson DG. Increased response to insulin of glucose metabolism in the six-day unloaded rat soleus muscle. J Biol Chem 261: 10707-10712, 1986.
16. Hong M, Chen DC, Klein PS, and Lee VM. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J Biol Chem 272: 25326-25332, 1997.
17. Kern M, Wells JA, Stephens JM, Elton CW, Friedman JE, Tapscott EB, Pekala PH, and Dohm GL. Insulin responsiveness in skeletal muscle is determined by glucose transporter (Glut4) protein level. Biochem J 270: 397-400, 1990.
18. Klein PS and Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93: 8455-8459, 1996.
19. Lochhead PA, Coghlan M, Rice SQJ, and Sutherland C. Inhibition of GSK-3 selectively reduces glucose-6-phosphate and phosphoenolpyruvate carboxykinase gene expression. Diabetes 50:937-946, 2001.
20. Nesher R, Karl IE, Kaiser KK, and Kipnis DM. Epitrochlearis muscle. I. Mechanical performance, energetics, and fiber composition. Am J Physiol Endocrinol Metab 239: E454-E460, 1980.
21. Nikoulina SE, Cirialdi TP, Mudaliar S, Carter L, Johnson K, and Henry RR. Inhibition of glycogen synthase kinase-3 improves insulin action and glucose metabolism in human skeletal muscle. Diabetes 51: 2190-2198, 2002.
22. Nikoulina SE, Cirialdi TP, Mudaliar S, Mohideen P, Carter L, and Henry RR. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes 49: 263-271, 2000.
23. Orena SJ, Torchia AJ, and Garofalo RS. Inhibition of glycogen synthase kinase-3 stimulates glycogen synthase and glucose transport by distinct mechanisms in 3T3-L1 adipocytes. J Biol Chem 275:15765-15772, 2000.
24. Parker PJ, Caudwell FB, and Cohen P. Glycogen synthase from rabbit skeletal muscle: effect of insulin on the state of phosphorylation of the seven phosphoserine residues in vivo. Eur J Biochem 130: 227-234, 1983.
25. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 44: 121-131, 1993.
26. Ring D, Johnson KW, Henriksen EJ, Nuss JM, Goff D, Kinnick TR, Ma ST, Reeder JW, Samuels I, Slabiak T, Wagman A, Wernette-Hammond ME, and Harrison SD. Selective GSK3 inhibitors potentiate insulin action on glucose transport and utilization in vitro and in vivo. Diabetes. In press.
27. Roach PJ. Control of glycogen synthase by hierarchal protein phosphorylation. FASEB J 4: 2961-2968, 1990.
28. Rodnick KJ, Henriksen EJ, James DE, and Holloszy JO. Exercise training, glucose transporters, and glucose transport in rat skeletal muscles. Am J Physiol Cell Physiol 262: C9-C14, 1992.
29. Sherman WM, Katz AL, Cutler CL, Withers RT, and Ivy JL. Glucose transport: locus of muscle insulin resistance in obese Zucker rats. Am J Physiol Endocrinol Metab 255: E374-E382, 1988.
30. Song XM, Ryder JW, Kawano Y, Chibalin AV, Krook A, and Zierath JR. Muscle fiber type specificity in insulin signal transduction. Am J Physiol Regul Integr Comp Physiol 277: R1690-R1696, 1999.
31. Stambolic V, Ruel L, and Woodgett JR. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6: 1664-1668, 1996.
32. Summers SA, Kao AW, Kohn AD, Backus GS, Roth RR, Pessin JE, and Birnbaum MJ. The role of glycogen synthase kinase 3β in insulin-stimulated glucose metabolism. J Biol Chem 274: 17934-17940, 1999.
33. Tabata I, Schluter J, Gulve EA, and Holloszy JO. Lithium increases susceptibility of muscle glucose transport to stimulation by various agents. Diabetes 43: 903-907, 1994.
34. 14C-glucose. Anal Biochem 25: 486-499, 1968.
35. Woodgett JR. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J 9: 2431-2438, 1990.
36. Zhang W, DePaoli-Roach AA, and Roach PJ. Mechanisms of multisite phosphorylation and inactivation of rabbit muscle glycogen synthase. Arch Biochem Biophys 304: 219-225, 1993.
37. Zierath JR, Krook A, and Wallberg-Henriksson H. Insulin action and insulin resistance in human skeletal muscle. Diabetologia 43: 821-835, 2000.